Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Hosp Pharm ; 59(1): 10-14, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38223863

RESUMEN

DRESS related to first-line antituberculosis drugs (ATD) is a challenging diagnosis. With a long-lasting combined treatment of 4-concomitantly administrated drugs, identification of the culprit drug remains difficult and may expose patients to treatment interruption and affect their outcome. A 42-year-old female, treated with isoniazid, rifampicin, pyrazinamide and ethambutol for multifocal tuberculosis, developed, 40 days later, hyperthermia, facial edema, cervical lymphadenopathy and generalized exanthema. Biological test results revealed eosinophilia, atypical lymphocytes, and liver injury. DRESS was suspected, and ATD were withdrawn. As patch tests for the 4 ATD showed negative results, we decided to reintroduce pyrazinamide, ethambutol and rifampicin separately with a 3-day interval. Pyrazinamide and rifampicin were tolerated. However, after receiving ethambutol, she developed fever and generalized rash, with no biological abnormalities. Since ethambutol was claimed to be the culprit drug, isoniazid was added, and 10 hours later, the patient developed fever, facial edema, generalized rash, eosinophilia and liver injury. This clinical and biological pattern resolved 2 weeks later. This report suggests a hypersensitivity relapse to ethambutol after isoniazid-induced DRESS.

3.
Pan Afr Med J ; 42: 306, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36425541

RESUMEN

Fungal necrotizing external otitis (NEO) is a rare disease. It is an aggressive and potentially fatal infection. The most commonly reported pathogen is Candida. We aim through this study to share our experience in the management of fungal necrotizing external otitis and discuss its diagnosis tools, anti-fungal treatment choice, and outcomes. We included fifteen patients with diagnosis criteria of fungal NEO; clinical features of NEO with positive culture swabs and/or positive serologic test to a fungal pathogen. The mean age was of 70 years with a prevalence of males. The main symptoms were otalgia (n=15) and otorrhea (n=7). Facial palsy was observed in four cases. Fungal pathogens were Candida(n=10) and Aspergillus (n=5). Complications were observed in eight cases: extension to the temporo-mandibular (n=4), abscess in the retropharyngeal space (n=2), abscess in the parapharyngeal space (n=1) and thrombophlebitis of the internal jugular vein (n=1). Six patients were treated with fluconazole, eight with voriconazole, and one patient with itraconazole. After a mean duration of 52 days of antifungal therapy, fourteen patients have been cured with normalization of the ear symptoms, biological, and imaging features. One patient died of septic shock. No recurrence of the disease was observed after a follow-up of 12 months in all cases.


Asunto(s)
Otitis Externa , Otomicosis , Masculino , Humanos , Anciano , Femenino , Otitis Externa/diagnóstico , Otitis Externa/tratamiento farmacológico , Otitis Externa/microbiología , Antifúngicos/uso terapéutico , Absceso/tratamiento farmacológico , Otomicosis/diagnóstico , Otomicosis/tratamiento farmacológico , Voriconazol/uso terapéutico , Candida
4.
Indian J Dermatol Venereol Leprol ; 88(3): 349-353, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-33871210

RESUMEN

Mycoplasma pneumoniae is a well-known cause of community-acquired pneumonia, mostly associated with dermatological manifestations especially with mucosal involvement and targetoid cutaneous lesions. For many years, it was considered among the spectrum of erythema multiforme. Recently, some authors have recommended the creation of a new syndrome called "mycoplasma-induced rash and mucositis." This new syndrome has distinct epidemiological, clinical and histological features making it different from drug-induced Stevens-Johnson syndrome, toxic epidermal necrosis and erythema multiforme. Herein, we report two patients with acute Mycoplasma pneumoniae respiratory tract infection presenting severe mucocutaneous lesions in accordance with this new syndrome.


Asunto(s)
Eritema Multiforme , Exantema , Mucositis , Neumonía por Mycoplasma , Síndrome de Stevens-Johnson , Eritema Multiforme/complicaciones , Eritema Multiforme/diagnóstico , Exantema/etiología , Humanos , Mucositis/inducido químicamente , Mucositis/complicaciones , Mucositis/diagnóstico , Mycoplasma pneumoniae , Neumonía por Mycoplasma/complicaciones , Neumonía por Mycoplasma/diagnóstico , Síndrome de Stevens-Johnson/diagnóstico
5.
Pan Afr Med J ; 38: 349, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34367428

RESUMEN

Nocardia infection is an uncommon and rare condition in immunocompetent patient. A case of cutaneous nocardiosis complicated with osteomyelitis of the vault scalp in a 64-year-old man, with no remarkable past medical history, is reported. Treatment with trimethoprime-sulfamethoxazole than doxycycline for 12 months led to complete resolution and no evidence of recurrence was noted. Nocardia infection should be considered even in immunocomptent patients and doxycycline is a good alternative for treatment.


Asunto(s)
Antibacterianos/administración & dosificación , Nocardiosis/diagnóstico , Osteomielitis/diagnóstico , Cráneo/patología , Doxiciclina/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Nocardiosis/complicaciones , Nocardiosis/tratamiento farmacológico , Osteomielitis/tratamiento farmacológico , Osteomielitis/microbiología , Cráneo/microbiología , Combinación Trimetoprim y Sulfametoxazol/administración & dosificación
6.
J Otol ; 16(1): 22-26, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33505446

RESUMEN

INTRODUCTION: Necrotising otitis externa (NOE) is a rare infection of the ear canal with frequent bone erosion. This study's objective is to describe the different features of NOE as well as its management in an ear-nose-throat department. We also tried to identify the particularities of the fungal infection. PATIENTS AND METHODS: It is an observational cohort that included all the patients hospitalised for the management of NOE. The study was carried out in the ear-nose-throat Department of Mahdia University Hospital in Tunisia between January 2006 and december 2019. RESULTS: A total of 40 patients were included. The mean age was 65 ± 12.9 years and the sex ratio was 0.9. Ninety percent of the patients included were diabetics. The most common signs found were oedema of the external canal (97.5%) and auricular discharge (92.5%). The main pathogen isolated was Pseudomonas aeruginosa (61.7%). Fungi were isolated in 9 cases (26.47%). Computed tomography was performed for 32 patients (80%). Bone erosion was seen in 26 cases (81.3%). The main complications were cerebral venous thrombosis, retropharyngeal abscess and cerebral empyema. Thirty one patients received only antibiotics, 2 received only antifungal treatment, and 7 received both antibiotics and antifungal treatment. All patients had a favorable outcome. Univariate analysis showed a higher median erythrocyte sedimentation rate was associated with fungal infections. No other differences were noted. CONCLUSION: Our management protocol seems to be efficient since all patients had initial favorable outcome. A higher median erythrocyte sedimentation rate was associated with fungal infections.

7.
Front Med (Lausanne) ; 7: 503, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32984380

RESUMEN

Antimicrobial stewardship (AMS) is a set of coordinated strategies to improve the use of antimicrobials, to enhance patient outcomes, reduce antimicrobial resistance, and decrease unnecessary costs. The pioneer years of AMS were restricted to high-income countries (HIC), where overconsumption of antibiotics was associated with emergence of multidrug-resistant (MDR) bacteria. AMS in low- and middle-income countries (LMIC) is also necessary. However, programs effective in HIC may not perform as well in LMIC, because (i) While decreased consumption of antibiotics may be an appropriate target in overconsuming HIC, this may be dangerous in LMIC, where many patients die from the lack of access to antibiotics; (ii) although AMS programs in HIC can be designed and monitored through laboratory surveillance of resistance, surveillance programs are not available in many LMIC; (iii) the heterogeneity of health care systems implies that AMS programs must be carefully contextualized. Despite the need to individually tailor AMS programs in LMIC, international collaborations remain highly valuable, through the dissemination of high-quality documents and educational material, that may be shared, adapted where needed, and adopted worldwide. This process, facilitated by modern communication tools, combines many benefits, including: (i) saving time, a precious dimension for health care workers, by avoiding the duplication of similar works in different settings; (ii) taking advantage of colleagues skills, and initiatives, through open access to the work performed in other parts of the world; (iii) sharing experiences, so that we all learn from each others' successes and failures.

8.
Tunis Med ; 98(4): 304-308, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32395793

RESUMEN

SARS-CoV-2 infection has to be confirmed by virological diagnosis. Multiple diagnostic tests are available without enough perspective on their reliability. Therefore, it is important to choose the most suitable test according to its sensitivity and specificity but also to the stage of the disease. Currently, the RT-PCR detection of the viral genome in respiratory samples is the most reliable test to confirm the diagnosis of an acute SARS-CoV-2 infection. It has to be done in Class II biological safety laboratory. However, it may lack sensitivity, particularly in the advanced phase of infection, and depends closely on the samples' quality. Rapid PCR by cartridge system reduces response times but is not suitable for laboratories with high throughput of requests. Detection of virus antigens on respiratory samples is a quick and easy to use technique; however it has not good specificity and sensitivity and cannot be used for diagnosis and patient management. The detection of specific antibodies against SARS-CoV-2 is better used for epidemiological analyses. Research should be encouraged to overcome the limits of the currently available diagnostic tests.


Asunto(s)
Betacoronavirus/genética , Infecciones por Coronavirus/diagnóstico , Neumonía Viral/diagnóstico , COVID-19 , Infecciones por Coronavirus/virología , Humanos , Pandemias , Neumonía Viral/virología , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducibilidad de los Resultados , SARS-CoV-2 , Sensibilidad y Especificidad
9.
Tunis Med ; 98(8-9): 639-642, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33480019

RESUMEN

OBJECTIVES: Diagnosis of SARS-CoV-2 infection is a major public health issue. In a context of limited diagnostic capacity with the reference technique (real-time RT-PCR), many manufacturers have developed rapid diagnostic tests (RDTs). Although very promising in theory, these tests have raised many questions. This article is a rapid review that synthesizes data regarding different types of available RDTs, their performance, their limits and their potential indications in Tunisia as proposed by a multidisciplinary group of experts. METHODS: A literature review was carried out on the websites of international organizations, governmental bodies and on INAHTA database, completed by a search of relevant scientific articles up to 1 June 2020. The synthesis of the data was submitted to a panel of experts to propose recommendations for the Tunisian context. RESULTS: RDTs based on the detection of antigens and antibodies have sensitivity and specificity related issues. Few validation reports are published in the scientific literature. Pending more evidence on their performance and validity, several international organizations recommend their use only for research purposes. TDRs based on antibody detection are not appropriate for the early diagnosis of COVID-19. However, validated and specific tests could provide complementary diagnostic information to reference tests. CONCLUSION: Pending further evidence, the panel recommends the use of RDTs mainly for research purposes at the community level.


Asunto(s)
Prueba de COVID-19/métodos , COVID-19/diagnóstico , Humanos , Factores de Tiempo , Túnez
12.
J Glob Antimicrob Resist ; 5: 62-3, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27436468

RESUMEN

Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis.


Asunto(s)
Infecciones por Acinetobacter/tratamiento farmacológico , Acinetobacter baumannii/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple , Meningitis/tratamiento farmacológico , Minociclina/análogos & derivados , Adulto , Antibacterianos/uso terapéutico , Colistina , Humanos , Masculino , Meningitis/microbiología , Pruebas de Sensibilidad Microbiana , Minociclina/uso terapéutico , Tigeciclina
13.
BMC Infect Dis ; 16: 156, 2016 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-27084753

RESUMEN

BACKGROUND: Urinary tract infection (UTI) among patients with neurogenic bladder is a major problem but its management is not well known. We studied the relationship between antibiotic regimen use and the cure rate of those infections among 112 patients with neurogenic bladder. METHODS: We studied a retrospective cohort of febrile UTI among patients with neurogenic bladder. Drug selection was left to the discretion of the treating physicians, in accordance with current guidelines. Patients were divided into 3 groups according to antibiotic treatment duration (<10 days, between 10 and 15 days, and >15 days). We analysed clinical and microbiogical cure rate one month after the end of antibiotic treatment. RESULTS: The three groups of patients were similar, especially in terms of drug treatment (equal distribution). The cure rates were not significantly different (71.4 %, 54.2 %, and 57.1 %, respectively; p = 0.34). Moreover, there was no difference in cure rate between mono and dual therapy (44 % for monotherapy vs. 40 % for dual therapy; p = 0.71). CONCLUSION: This descriptive study supports the efficacy of antimicrobial treatment duration of less than 10 days and the use of monotherapy to treat febrile UTI among patients with neurogenic bladder. A randomized control trial is required to confirm these data.


Asunto(s)
Antibacterianos/uso terapéutico , Traumatismos de la Médula Espinal/diagnóstico , Infecciones Urinarias/tratamiento farmacológico , Adulto , Estudios de Cohortes , Quimioterapia Combinada , Enterococcus/aislamiento & purificación , Escherichia coli/aislamiento & purificación , Femenino , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Pseudomonas aeruginosa/aislamiento & purificación , Estudios Retrospectivos , Traumatismos de la Médula Espinal/complicaciones , Vejiga Urinaria Neurogénica/complicaciones , Infecciones Urinarias/complicaciones , Infecciones Urinarias/microbiología
17.
J Clin Pharmacol ; 49(12): 1488-91, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19723672

RESUMEN

A 14-year-old male presents with erythroderma and fever 44 days after carbamazepine intake. Laboratory exams show eosinophilia and elevated liver enzymes, and thoracic imaging reveals interstitial pneumonitis. All symptoms disappear after carbamazepine withdrawal. A patch test to carbamazepine performed 6 weeks after recovery is positive. About 8 months later, the patient exhibits the same clinical and biological picture 52 days after lamotrigine intake. Lamotrigine is stopped and all symptoms disappear. A patch test to LMG is positive. This case illustrates a possible cross-reactivity between carbamazepine and lamotrigine, which are aromatic and nonaromatic anticonvulsants, respectively.


Asunto(s)
Anticonvulsivantes/efectos adversos , Carbamazepina/efectos adversos , Erupciones por Medicamentos/etiología , Hipersensibilidad a las Drogas/inmunología , Triazinas/efectos adversos , Adolescente , Anticonvulsivantes/inmunología , Carbamazepina/inmunología , Reacciones Cruzadas , Erupciones por Medicamentos/patología , Hipersensibilidad a las Drogas/patología , Humanos , Lamotrigina , Masculino , Pruebas del Parche , Piel/efectos de los fármacos , Piel/patología , Síndrome , Triazinas/inmunología
18.
Tunis Med ; 84(3): 161-4, 2006 Mar.
Artículo en Francés | MEDLINE | ID: mdl-16755956

RESUMEN

UNLABELLED: The pathogenic capacity of streptococcus agalactiae or Group B Streptococcus (GBS) has been increasing in nonpregnant adults. We carried out a study about the pathogenic capacity and susceptibility to antibiotics of GBS strains isolated between January 2003 and June 2004 in Farhat Hached hospital of Sousse (Tunisian general hospital). METHODS: Identification of strains was carried out according to usual bacteriological characters. Susceptibility of GBS to antibiotics was carried out according to CA-SFM recommendations. RESULTS: during the study period, sixty strains were isolated. They were essentially isolated from the urinary tract (52%) and the skin (36.2%). Women accounted for 68 percent of the cases. Among the 30 hospitalized patients, 20 (66%) had serious underlying disease. Diabetes mellitus was predominant (80%). All group B streptococci isolates were susceptible to amoxicillin, penicillin G, vancomycin and to pristinamycin. Sixty four percent of isolates were susceptible to erythromycin. Among the invasive infection, caused by GBS in nonpregnant adults, skin and urinary tract infections were the most common. All isolates were susceptible to amoxicillin, penicillin G. vancomycin and to pristinamycin.


Asunto(s)
Infecciones Estreptocócicas/epidemiología , Streptococcus agalactiae/aislamiento & purificación , Antibacterianos/uso terapéutico , Femenino , Humanos , Masculino , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico , Enfermedades Cutáneas Infecciosas/microbiología , Infecciones Estreptocócicas/tratamiento farmacológico , Túnez/epidemiología , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología
19.
Tunis Med ; 83(1): 18-23, 2005 Jan.
Artículo en Francés | MEDLINE | ID: mdl-15881716

RESUMEN

The aim of this study is to evaluate the frequency of infectious urgencies and the quality of their management in an emergency medical service. During the period of study, 21737 consultants are recorded, from which 2011 for an infectious urgency (9,25%), pharyngitis with rhinitis excluded. 692 patients are hospitalized and 1074 receive ambulatory antibiotics. Therapeutic urgencies are the most frequent infectious urgencies (48,4%), followed by protection urgencies (46,3%), urgencies due to antibiotics (5,2%) and prevention urgencies (0,1%). The conduct is considered correct for 1379 cases (68,5%) and incorrect for 500 cases (25%). Main incorrect conducts are the absence of follow-up (81,6%) and the maladjusted antibiotherapy (11,8%). These results incite, mainly, to the improvement of the professional training of emergency physicians and their communication with their colleagues of the other sanitary structures.


Asunto(s)
Servicio de Urgencia en Hospital , Infecciones/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Atención Ambulatoria/estadística & datos numéricos , Antibacterianos/uso terapéutico , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Infecciones/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Túnez/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...